P

Inventor

POPOVICI-MULLER JANETA

US46 patents
⚠️ This page may combine multiple inventors who share the name “POPOVICI-MULLER JANETA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

AGIOS PHARMACEUTICALS INC

25 patents
US9474779B2Oct 25, 2016

Therapeutically active compositions and their methods of use

AGIOS PHARMACEUTICALS INC36 citations97
US9579324B2Feb 28, 2017

Therapeutically active compounds and their methods of use

AGIOS PHARMACEUTICALS INC22 citations94
US9512107B2Dec 6, 2016

Therapeutically active compositions and their methods of use

AGIOS PHARMACEUTICALS INC25 citations94
US9850277B2Dec 26, 2017

Therapeutically active compositions and their methods of use

AGIOS PHARMACEUTICALS INC22 citations93
US9732062B2Aug 15, 2017

Therapeutically active compounds and their methods of use

AGIOS PHARMACEUTICALS INC18 citations92
US9656999B2May 23, 2017

Therapeutically active compounds and their methods of use

AGIOS PHARMACEUTICALS INC16 citations92
US10294215B2May 21, 2019

Therapeutically active compounds and their methods of use

AGIOS PHARMACEUTICALS INC6 citations84
US10172864B2Jan 8, 2019

Therapeutically active compounds and their methods of use

AGIOS PHARMACEUTICALS INC8 citations84
US9458132B2Oct 4, 2016

Therapeutic compounds and compositions and their use as PKM2 modulators

AGIOS PHARMACEUTICALS INC18 citations84
US11505538B1Nov 22, 2022

Therapeutically active compounds and their methods of use

AGIOS PHARMACEUTICALS INC1 citations73
US10028961B2Jul 24, 2018

Therapeutically active compounds and their methods of use

AGIOS PHARMACEUTICALS INC4 citations73
US10717764B2Jul 21, 2020

Therapeutically active compounds and their methods of use

AGIOS PHARMACEUTICALS INC1 citations72
US10640534B2May 5, 2020

Therapeutically active compositions and their methods of use

AGIOS PHARMACEUTICALS INC2 citations72
US10376510B2Aug 13, 2019

2,4- or 4,6-diaminopyrimidine compounds as IDH2 mutants inhibitors for the treatment of cancer

AGIOS PHARMACEUTICALS INC3 citations72
US11524960B2Dec 13, 2022

Heterobicyclic inhibitors of MAT2A and methods of use for treating cancer

AGIOS PHARMACEUTICALS INC2 citations65
US11021515B2Jun 1, 2021

Therapeutically active compounds and their methods of use

AGIOS PHARMACEUTICALS INC0 citations62
US10946023B2Mar 16, 2021

Therapeutically active compounds and their methods of use

AGIOS PHARMACEUTICALS INC0 citations62
US10202339B2Feb 12, 2019

Therapeutic compounds and compositions

AGIOS PHARMACEUTICALS INC1 citations62
US10011574B2Jul 3, 2018

Glutaminase inhibitors and method of use

AGIOS PHARMACEUTICALS INC1 citations62
US10689375B2Jun 23, 2020

Compounds and their methods of use

AGIOS PHARMACEUTICALS INC0 citations52
US10414740B2Sep 17, 2019

Glutaminase inhibitors and method of use

AGIOS PHARMACEUTICALS INC0 citations52
US10087172B2Oct 2, 2018

Compounds and their methods of use

AGIOS PHARMACEUTICALS INC0 citations52
US10689414B2Jun 23, 2020

Therapeutically active compounds and their methods of use

AGIOS PHARMACEUTICALS INC0 citations51
US9856279B2Jan 2, 2018

Therapeutically active compositions and their methods of use

AGIOS PHARMACEUTICALS INC1 citations51
US9365545B2Jun 14, 2016

Therapeutic compounds and compositions

AGIOS PHARMACEUTICALS INC0 citations51

SCHERING CORP

10 patents

SERVIER PHARMACEUTICALS LLC

3 patents

LEMIEUX RENE M

2 patents

LAVEY BRIAN J

1 patent

TONG LING

1 patent

CIANCHETTA GIOVANNI

1 patent

KOZLOWSKI JOSEPH A

1 patent

CAO SHELDON

1 patent

POPOVICI-MULLER JANETA

1 patent